Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
22 March 2022Website:
http://www.embecta.comNext earnings report:
08 August 2024Last dividends:
24 May 2024Next dividends:
N/APrice
after hours | Fri, 05 Jul 2024 20:20:00 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
EMBC Latest News
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association's 84th Scientific Sessions that point to the potential for adults with type 2 diabetes (T2D) to better manage insulin delivery through a patch pump with a larger, 300-unit (u) insulin reservoir, which could provide longer wear times and fewer disposable patches over time.
The White House recently confirmed increased tariffs on various Chinese goods. Investors and traders are on the lookout for stocks to benefit from China tariffs as the change could significantly impact many industries, including the U.S. automotive industry, electric vehicles (EVs) and others.
Embecta (EMBC) CEO Dev Kurdikar sits down with Oliver Renick to provide an overview of the company and delve into its second quarter earnings. Additionally, he addresses the influence of GLP-1 medications.
XRX, EMBC and HMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 12, 2023.
Embecta beat Wall Street estimates with its fiscal 2024 Q1 revenue and earnings. The company's full-year outlook, though, came in below consensus estimates.
Embecta Corp. (EMBC) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.96 per share a year ago.
PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, February 9, 2024.
PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following investor events:
Embecta Corp. (EMBC) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.73 per share a year ago.
Embecta Corp. (NASDAQ:EMBC ) Q3 2023 Earnings Conference Call August 8, 2023 8:00 AM ET Company Participants Pravesh Khandelwal - Vice President of Investor Relations Dev Kurdikar - Chief Executive Officer Jake Elguicze - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley Marie Thibault - BTIG Travis Steed - Bank of America Securities Operator Welcome, ladies and gentlemen, to the Fiscal Third Quarter 2023 Embecta Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay following the completion of this call.
What type of business is Embecta?
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
What sector is Embecta in?
Embecta is in the Healthcare sector
What industry is Embecta in?
Embecta is in the Medical Instruments & Supplies industry
What country is Embecta from?
Embecta is headquartered in United States
When did Embecta go public?
Embecta initial public offering (IPO) was on 22 March 2022
What is Embecta website?
https://www.embecta.com
Is Embecta in the S&P 500?
No, Embecta is not included in the S&P 500 index
Is Embecta in the NASDAQ 100?
No, Embecta is not included in the NASDAQ 100 index
Is Embecta in the Dow Jones?
No, Embecta is not included in the Dow Jones index
When does Embecta report earnings?
The next expected earnings date for Embecta is 08 August 2024